Renal resistance index is a marker of future renal dysfunction in patients with essential hypertension

Journal of Nephrology

Volumn 23, Issue 2, 2010, Pages 175-180

  Okura, Takafumi ^a   Kurata, Mie ^a   Irita, Jun ^a   Enomoto, Daijiro ^a   Jotoku, Masanori ^a   Nagao, Tomoaki ^a   Koresawa, Mitsuko ^a   Kojima, Shiho ^b   Hamano, Yasuyuki ^b   Mashiba, Shinichi ^b   Miyoshi, Ken Ichi ^a   Higaki, Jitsuo ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Ikagaku Co Ltd   (Japan)

Author keywords

Creatinine; Cystatin C; Renal Doppler sonography; Renal function

Indexed keywords

C REACTIVE PROTEIN; CYSTATIN C; HEMOGLOBIN A1C;

ADULT; AGE DISTRIBUTION; AGED; ALBUMIN URINE LEVEL; ARTICLE; CREATININE URINE LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE MARKER; ESSENTIAL HYPERTENSION; FEMALE; FUNCTIONAL ASSESSMENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; PULSE PRESSURE; RENAL RESISTANCE INDEX; SYSTOLIC BLOOD PRESSURE; URINE LEVEL;

AGE FACTORS; AGED; ALBUMINURIA; BIOLOGICAL MARKERS; BLOOD PRESSURE; CREATININE; CYSTATIN C; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RENAL CIRCULATION; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VASCULAR RESISTANCE;

EID: 77749237062     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Norris CS, Barnes RW. Renal artery flow velocity analysis: a sensitive measure of experimental and clinical renovascular resistance. J Surg Res. 1984;36:230-236.
2. Avasthi PS, Voyles WF, Greene ER. Noninvasive diagnosis of renal artery stenosis by echo-Doppler velocimetry. Kidney Int. 1984;25:824-829.
3. Lee SK, Wang ML, Su YG, et al. Detection of renal allograft dysfunction with color doppler flow ultrasound. Zhonghua Yi Xue Za Zhi (Taipei). 1993;51:257-265.
4. Okura T, Watanabe S, Miyoshi K, et al. Intrarenal and carotid hemodynamics in patients with essential hypertension. Am J Hypertens. 2004;17:240-244.
5. Petersen LJ, Petersen JR, Talleruphuus U, et al. The pulsatility index and the resistive index in renal arteries: associations with long-term progression in chronic renal failure. Nephrol Dial Transplant. 1997;12:1376-1380.
6. Radermacher J, Ellis S, Haller H. Renal resistance index and progression of renal disease. Hypertension. 2002;39:699-703.
7. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington diabetes survey. Lancet 1988;2:530-533.
8. Damsgaard EM, Froland A, Jorgensen OD, et al. Microalbuminuria as predictor of increased mortality in elderly people. BMJ. 1990;300:297-300.
9. Simonsen O, Grubb A, Thysell H. The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate. Scand J Clin Lab Invest. 1985;45:97-101.
10. Tian S, Kusano E, Ohara T, et al. Cystatin C measurement and its practical use in patients with various renal diseases. Clin Nephrol. 1997;48:104-108.
11. Newman DJ, Thakkar H, Edwards RG, et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int. 1995;47:312-318.
12. Arimoto T, Takeishi Y, Niizeki T, et al. Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure. J Card Fail. 2005;11:595-601.
13. Shlipak MG, Katz R, Sarnak MJ, et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med. 2006;145:237-246.
14. Ix JH, Shlipak MG, Chertow GM, et al. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: Data from the heart and soul study. Circulation. 2007;115:173-179.
15. Watanabe S, Okura T, Liu J, et al. Serum cystatin C level is a marker of end-organ damage in patients with essential hypertension. Hypertens Res. 2003;26:895-899.
16. Watanabe S, Okura T, Kurata M, et al. Valsartan reduces serum cystatin C and the renal vascular resistance in patients with essential hypertension. Clin Exp Hypertens. 2006;28:451-461.
17. Tedesco MA, Natale F, Mocerino R, et al. Renal resistive index and cardiovascular organ damage in a large population of hypertensive patients. J Hum Hypertens. 2007;21:291-296.
18. Pontremoli R, Viazzi F, Martinoli C, et al. Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. Nephrol Dial Transplant. 1999;14:360-365.
19. Mostbeck GH, Kain R, Mallek R, et al. Duplex Doppler sonography in renal parenchymal disease: histopathologic correlation. J Ultrasound Med. 1991;10:189-194.
20. Ikee R, Kobayashi S, Hemmi N, et al. Correlation between the resistive index by Doppler ultrasound and kidney function and histology. Am J Kidney Dis. 2005;46:603-609.
21. Tracy RE, Malcom GT, Oalmann MC, et al. Renal microvascular features of hypertension in Japan, Guatemala, and the United States. Arch Pathol Lab Med. 1992;116:50-55.
22. Kyhse-Andersen J, Schmidt C, Nordin G, et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem. 1994;40:1921-1926.
23. Sarnak MJ, Katz R, Stehman-Breen CO, et al. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med. 2005;142:497-505.
24. Shlipak MG, Katz R, Cushman M, et al. Cystatin-C and inflammatory markers in the ambulatory elderly. Am J Med. 2005;118:1416.